Healthcare firm Tata 1mg has made an investment of an undisclosed amount in the diagnostic venture 5C Network. The other participants were Vikram Vuppala of Nephroplus, Om Manchanda of Lal Pathlabs and Viren Prasad Shetty of Narayana Health and more. 

They are India's first diagnostics network, that strives to make Radiodiagnosis more Accessible, Affordable and Accurate in India. 5C Network has previously gained $1.2 million from Unitus Ventures and Axilor Ventures, in 2020. In 2019, they had gained seed funds from IIM Calcutta Innovation Park.

The venture was founded by Kalyan Sivasailam and Syed Ahmed in 2016. They help hospitals and other medical centres to optimise their radiology machines by providing them, with specialists. 

1 mg was founded by Tandon, Gaurav Agarwal and Vikas Chauhan in 2011. Last year in the month of June, Tata Digital, a subsidiary of Tata Group acquired a majority stake in the venture 1mg. Turing it into Tata 1 mg. 

They provide services such as e-pharmacy, e-consultation and more. The current investment in 5C Network helps Tata 1 mg expand its portfolio. 

With its AI technology, 5C Network has reported analysis on complex radiology cases in just an hour. They have so far delivered their diagnosis to over 3.5 million patients across 27 states of India.